Inhibition of the mevalonate pathway potentiates the effects of lenalidomide in myeloma.

DSpace/Manakin Repository

van der Spek, E.; Bloem, A.C.; Lokhorst, H.M.; van Kessel, B.; Bogers - Boer, L.H.; van de Donk, N.W.C.J.

(2009) Leukemia Research, volume 33, issue 1, pp. 100 - 108

(Article)

Download/Full Text

Embargo until January 01 2050

ISSN: 0145-2126

Publisher: Elsevier Limited

(Peer reviewed)

See more statistics about this item